Doug Besch - Dec 19, 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Product Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
Dec 19, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2024, 06:25 PM
Previous filing
Oct 6, 2023
Next filing
Apr 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +5.89K $0.00 5.89K Dec 19, 2023 Common Stock 5.89K $12.73 Direct F1
transaction OPRX Restricted Stock Units Award $0 +5.89K $0.00 5.89K Dec 19, 2023 Common Stock 5.89K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.